Shuren: Budget Woes Will Have Big Impact On FDA Device Center
This article was originally published in The Gray Sheet
Executive Summary
Pre-market review of device applications, among other core CDRH activities, would come to a virtual halt in the event of a federal government shutdown, according to Center Director Jeffrey Shuren.